{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T15:23:37Z","timestamp":1761578617737},"reference-count":25,"publisher":"Europa Digital & Publishing","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["EuroIntervention"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.4244\/eij-d-17-00246","type":"journal-article","created":{"date-parts":[[2017,7,23]],"date-time":"2017-07-23T07:26:00Z","timestamp":1500794760000},"page":"424-431","source":"Crossref","is-referenced-by-count":14,"title":["One-year clinical results of the Italian diffuse\/multivessel disease ABSORB prospective registry (IT-DISAPPEARS)"],"prefix":"10.4244","volume":"13","author":[{"given":"Luca","family":"Testa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"De Carlo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Petrolini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio","family":"Rapetto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ferdinando","family":"Varbella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernardo","family":"Cortese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriele","family":"Gabrielli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"Geraci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Loi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giacomo","family":"Boccuzzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Tarantini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dionigi","family":"Fischetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Calabria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabrizio","family":"Tomai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flavio","family":"Ribichini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corrado","family":"Tamburino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ciro","family":"Indolfi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Bartorelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Sonia","family":"Petronio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Bedogni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2774","reference":[{"key":"key-2017722201732-0","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0140-6736(14)61455-0","article-title":"A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial.","volume":"385","author":"Serruys PW.","year":"2015","journal-title":"Lancet."},{"key":"key-2017722201732-1","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1056\/NEJMoa1509038","article-title":"Everolimus-Eluting Bioresorbable Scaffolds for Coronary Artery Disease.","volume":"373","author":"Ellis SG.","year":"2015","journal-title":"N Engl J Med."},{"key":"key-2017722201732-2","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.4244\/EIJY14M08_08","article-title":"Initial experience and clinical evaluation of the Absorb bioresorbable vascular scaffold (BVS) in real-world practice: the AMC Single Centre Real World PCI Registry.","volume":"10","author":"Kraak RP.","year":"2015","journal-title":"EuroIntervention."},{"key":"key-2017722201732-3","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.4244\/EIJY14M07_11","article-title":"Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry.","volume":"10","author":"Capodanno D.","year":"2015","journal-title":"EuroIntervention."},{"key":"key-2017722201732-4","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S0140-6736(15)00979-4","article-title":"Everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a meta-analysis of randomised controlled trials.","volume":"387","author":"Cassese S.","year":"2016","journal-title":"Lancet."},{"key":"key-2017722201732-5","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(13)60141-5","article-title":"Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial.","volume":"381","author":"Mohr FW.","year":"2013","journal-title":"Lancet."},{"key":"key-2017722201732-6","first-page":"475","article-title":"[Technical features of Absorb(TM) BVS implantation in the IT-DISAPPEARS registry] [Article in Italian].","volume":"15","author":"Capranzano P.","year":"2014","journal-title":"G Ital Cardiol (Rome)."},{"key":"key-2017722201732-7","doi-asserted-by":"publisher","first-page":"253","DOI":"10.2459\/JCM.0000000000000219","article-title":"Italian Diffuse\/Multivessel Disease ABSORB Prospective Registry (IT-DISAPPEARS). Study design and rationale.","volume":"16","author":"Testa L.","year":"2015","journal-title":"J Cardiovasc Med (Hagerstown)."},{"key":"key-2017722201732-8","doi-asserted-by":"publisher","first-page":"2949","DOI":"10.1093\/eurheartj\/eht310.P4876","article-title":"2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology.","volume":"34","author":"Montalescot G.","year":"2013","journal-title":"Eur Heart J."},{"key":"key-2017722201732-9","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1093\/eurheartj\/ehv320","article-title":"2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC).","volume":"37","author":"Roffi M.","year":"2016","journal-title":"Eur Heart J."},{"key":"key-2017722201732-10","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1093\/eurheartj\/ehs215","article-title":"ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation.","volume":"33","author":"Steg PG.","year":"2012","journal-title":"Eur Heart J."},{"key":"key-2017722201732-11","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: a case for standardized definitions.","volume":"115","author":"Cutlip DE.","year":"2007","journal-title":"Circulation."},{"key":"key-2017722201732-12","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1093\/eurheartj\/ehs184","article-title":"Third universal definition of myocardial infarction.","volume":"33","author":"Thygesen K.","year":"2012","journal-title":"Eur Heart J."},{"key":"key-2017722201732-13","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.1016\/j.jacc.2015.09.054","article-title":"Bioresorbable Vascular Scaffolds Versus Metallic Stents in Patients With Coronary Artery Disease: ABSORB China Trial.","volume":"66","author":"Gao R.","year":"2015","journal-title":"J Am Coll Cardiol."},{"key":"key-2017722201732-14","doi-asserted-by":"publisher","first-page":"3332","DOI":"10.1093\/eurheartj\/ehv435","article-title":"A randomized trial evaluating everolimus-eluting Absorb bioresorbable scaffolds vs. everolimus-eluting metallic stents in patients with coronary artery disease: ABSORB Japan.","volume":"36","author":"Kimura T.","year":"2015","journal-title":"Eur Heart J."},{"key":"key-2017722201732-15","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/eurheartj\/ehv500","article-title":"Everolimus-eluting bioresorbable stent vs. durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction: results of the randomized ABSORB ST-segment elevation myocardial infarction-TROFI II trial.","volume":"37","author":"Sabat\u00e9 M.","year":"2016","journal-title":"Eur Heart J."},{"key":"key-2017722201732-16","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.jcin.2014.10.005","article-title":"Absorb bioresorbable vascular scaffold versus everolimus-eluting metallic stent in ST-segment elevation myocardial infarction: 1-year results of a propensity score matching comparison: the BVS-EXAMINATION Study (bioresorbable vascular scaffold-a clinical evaluation of everolimus eluting coronary stents in the treatment of patients with ST-segment elevation myocardial infarction).","volume":"8","author":"Brugaletta S.","year":"2015","journal-title":"JACC Cardiovasc Interv."},{"key":"key-2017722201732-17","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1002\/ccd.26346","article-title":"Angiographic and clinical outcomes of patients treated with everolimus-eluting bioresorbable stents in routine clinical practice: Results of the ISAR-ABSORB registry.","volume":"87","author":"Hoppmann P.","year":"2016","journal-title":"Catheter Cardiovasc Interv."},{"key":"key-2017722201732-18","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/j.jcin.2014.07.004","article-title":"Immediate, acute, and subacute thrombosis due to incomplete expansion of bioresorbable scaffolds.","volume":"7","author":"Gori T.","year":"2014","journal-title":"JACC Cardiovasc Interv."},{"key":"key-2017722201732-19","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.jcin.2016.12.013","article-title":"Bioresorbable Everolimus-Eluting Vascular Scaffold for Long Coronary Lesions: A Subanalysis of the International, Multicenter GHOST-EU Registry.","volume":"10","author":"Geraci S.","year":"2017","journal-title":"JACC Cardiovasc Interv."},{"key":"key-2017722201732-20","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ijcard.2016.01.202","article-title":"Bioresorbable Scaffold vs. Second Generation Drug Eluting Stent in Long Coronary Lesions requiring Overlap: A Propensity-Matched Comparison (the UNDERDOGS study).","volume":"208","author":"Biscaglia S.","year":"2016","journal-title":"Int J Cardiol."},{"key":"key-2017722201732-21","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jcin.2015.09.024","article-title":"Scaffold Thrombosis After Percutaneous Coronary Intervention With ABSORB Bioresorbable Vascular Scaffold: A Systematic Review and Meta-Analysis.","volume":"9","author":"Lipinski MJ.","year":"2016","journal-title":"JACC Cardiovasc Interv."},{"key":"key-2017722201732-22","article-title":"Coronary Bioresorbable Vascular Scaffold Use in the Treatment of Coronary Artery Disease.","volume":"9(7)","author":"Testa L.","year":"2016 Jul","journal-title":"Circ Cardiovasc Interv."},{"key":"key-2017722201732-23","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.4244\/EIJ-D-16-00974","article-title":"Predilation, sizing and post-dilation scoring in patients undergoing everolimus-eluting bioresorbable scaffold implantation for prediction of cardiac adverse events: development and internal validation of the PSP score.","volume":"12","author":"Ortega-Paz L.","year":"2017","journal-title":"EuroIntervention."},{"key":"key-2017722201732-24","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1056\/NEJMoa1614954","article-title":"Bioresorbable Scaffolds versus Metallic Stents in Routine PCI.","volume":"376","author":"Wykrzykowska JJ.","year":"2017","journal-title":"N Engl J Med."}],"container-title":["EuroIntervention"],"original-title":[],"deposited":{"date-parts":[[2017,7,23]],"date-time":"2017-07-23T07:26:14Z","timestamp":1500794774000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.pcronline.com\/eurointervention\/119th_issue\/66"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["EIJ-D-17-00246"],"URL":"https:\/\/doi.org\/10.4244\/eij-d-17-00246","relation":{},"ISSN":["1774-024X"],"issn-type":[{"value":"1774-024X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]}}}